Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 240

1.
2.
3.

Clinical and economic outcomes among patients with diabetes mellitus initiating insulin glargine pen versus vial.

Grabner M, Chu J, Raparla S, Quimbo R, Zhou S, Conoshenti J.

Postgrad Med. 2013 May;125(3):204-13. doi: 10.3810/pgm.2013.05.2656.

PMID:
23748521
4.
5.
6.

Does pen help? A real-world outcomes study of switching from vial to disposable pen among insulin glargine-treated patients with type 2 diabetes mellitus.

Xie L, Zhou S, Wei W, Gill J, Pan C, Baser O.

Diabetes Technol Ther. 2013 Mar;15(3):230-6. doi: 10.1089/dia.2012.0253. Epub 2013 Jan 21.

PMID:
23336845
7.
8.

The INITIATOR study: pilot data on real-world clinical and economic outcomes in US patients with type 2 diabetes initiating injectable therapy.

Thayer S, Wei W, Buysman E, Brekke L, Crown W, Grabner M, Raparla S, Quimbo R, Cziraky MJ, Hu W, Cuddihy R.

Adv Ther. 2013 Dec;30(12):1128-40. doi: 10.1007/s12325-013-0074-8. Epub 2013 Nov 30.

9.

A real-world study of patients with type 2 diabetes initiating basal insulins via disposable pens.

Xie L, Wei W, Pan C, Du J, Baser O.

Adv Ther. 2011 Nov;28(11):1000-11. doi: 10.1007/s12325-011-0074-5. Epub 2011 Oct 27.

PMID:
22038703
10.

Clinical and economic outcomes in patients with type 2 diabetes initiating insulin glargine disposable pen versus exenatide BID.

Baser O, Wei W, Baser E, Xie L.

J Med Econ. 2011;14(6):673-80. doi: 10.3111/13696998.2011.605818. Epub 2011 Sep 5.

PMID:
21892858
11.

Characteristics Relating to Adherence and Persistence to Basal Insulin Regimens Among Elderly Insulin-Naïve Patients with Type 2 Diabetes: Pre-Filled Pens versus Vials/Syringes.

Slabaugh SL, Bouchard JR, Li Y, Baltz JC, Meah YA, Moretz DC.

Adv Ther. 2015 Dec;32(12):1206-21. doi: 10.1007/s12325-015-0266-5. Epub 2015 Nov 13.

12.

Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.

Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL.

Clin Ther. 2006 Oct;28(10):1712-25; discussion 1710-1. Erratum in: Clin Ther. 2006 Nov;28(11):1968-9.

PMID:
17157128
13.

Differences in rates of hypoglycemia and health care costs in patients treated with insulin aspart in pens versus vials.

Asche CV, Luo W, Aagren M.

Curr Med Res Opin. 2013 Oct;29(10):1287-96. doi: 10.1185/03007995.2013.825590. Epub 2013 Aug 7.

PMID:
23865725
14.

Adherence and persistence to a regimen of basal insulin in a pre-filled pen compared to vial/syringe in insulin-naïve patients with type 2 diabetes.

Buysman E, Conner C, Aagren M, Bouchard J, Liu F.

Curr Med Res Opin. 2011 Sep;27(9):1709-17. doi: 10.1185/03007995.2011.598500. Epub 2011 Jul 11.

PMID:
21740289
15.

Adherence to premixed insulin in a prefilled pen compared with a vial/syringe in people with diabetes in Singapore.

Cheen HH, Lim SH, Huang MC, Bee YM, Wee HL.

Clin Ther. 2014 Jul 1;36(7):1043-53. doi: 10.1016/j.clinthera.2014.05.009. Epub 2014 Jun 7.

PMID:
24913030
16.

Comparison of utilization, cost, adherence, and hypoglycemia in patients with type 2 diabetes initiating rapid-acting insulin analog with prefilled pen versus vial/syringe.

Lee LJ, Li Q, Reynolds MW, Pawaskar MD, Corrigan SM.

J Med Econ. 2011;14(1):75-86. doi: 10.3111/13696998.2010.546466. Epub 2011 Jan 13.

PMID:
21231863
17.

Does Device Make Any Difference? A Real-world Retrospective Study of Insulin Treatment Among Elderly Patients With Type 2 Diabetes.

Miao R, Wei W, Lin J, Xie L, Baser O.

J Diabetes Sci Technol. 2014 Jan 1;8(1):150-158. [Epub ahead of print]

18.

A comparison of insulin use, glycemic control, and health care costs with insulin detemir and insulin glargine in insulin-naive patients with type 2 diabetes.

Borah BJ, Darkow T, Bouchard J, Aagren M, Forma F, Alemayehu B.

Clin Ther. 2009 Mar;31(3):623-31. doi: 10.1016/j.clinthera.2009.03.005.

PMID:
19393853
19.

Effect of glargine insulin delivery method (pen device versus vial/syringe) on glycemic control and patient preferences in patients with type 1 and type 2 diabetes.

Seggelke SA, Hawkins RM, Gibbs J, Rasouli N, Wang CC, Draznin B.

Endocr Pract. 2014 Jun;20(6):536-9. doi: 10.4158/EP13404.OR.

PMID:
24326004
20.
Items per page

Supplemental Content

Write to the Help Desk